JAMA Cardiology·Feb 4Abelacimab vs Rivaroxaban in Older Individuals With Atrial Fibrillation: A Prespecified Analysis of the Phase 2b AZALEA-TIMI 71 TrialRandomized trial in 1,287 peopleAtrial fibrillationPaper